Back to Search
Start Over
EMA|PRAC|765002|2018 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk Assessment Committee (PRAC)
- Source :
- European Union News. May 22, 2019
- Publication Year :
- 2019
-
Abstract
- Amsterdam: European Medicines Agency has issued the following document: is authorised provided the source is acknowledged. 29 October 2018 EMA/PRAC/765002/2018 Inspections, Human Medicines Pharmacovigilance and Committees Division Pharmacovigilance Risk Assessment [...]
- Subjects :
- Deferiprone
Empagliflozin
Apremilast
Fidaxomicin
Hypoglycemic agents
Micafungin
Rolapitant
Ambrisentan
Peramivir
Tolcapone
Edoxaban
Ticagrelor
Fenofibrate
Ramucirumab
Atazanavir
Emtricitabine
Ivacaftor
Febuxostat
Nivolumab
Osimertinib
Monoclonal antibodies
Miglustat
Rivaroxaban
Pembrolizumab
Lumacaftor
Bedaquiline
Florbetapir
Cariprazine
Bevacizumab
Antidepressants
Nintedanib
Silodosin
Eltrombopag
Turoctocog alfa
Risk assessment
Antineoplastic agents
Duloxetine
Canakinumab
Insulin aspart
Escitalopram
Everolimus
Alogliptin
Exenatide
Milnacipran
Certolizumab pegol
Insulin glargine
Ipilimumab
Drugs
Desvenlafaxine
Adalimumab
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- European Union News
- Publication Type :
- News
- Accession number :
- edsgcl.586448383